| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CDNA | Common Stock | Award | $0 | +302,000 | +113% | $0.000000 | 569,152 | 01 Feb 2023 | Direct | F1, F2 |
| transaction | CDNA | Common Stock | Award | $0 | +11,800 | +2.1% | $0.000000 | 580,952 | 01 Feb 2023 | Direct | F3 |
| transaction | CDNA | Common Stock | Tax liability | $36,488 | -2,330 | -0.4% | $15.66 | 578,622 | 01 Feb 2023 | Direct | F4 |
| transaction | CDNA | Common Stock | Sale | $39,542 | -2,316 | -0.4% | $17.07 | 576,306 | 02 Feb 2023 | Direct | F5, F6 |
| transaction | CDNA | Common Stock | Sale | $8,805 | -503 | -0.09% | $17.50 | 575,803 | 02 Feb 2023 | Direct | F5, F7 |
| transaction | CDNA | Common Stock | Tax liability | $127,567 | -7,244 | -1.3% | $17.61 | 568,559 | 02 Feb 2023 | Direct | F4 |
| transaction | CDNA | Common Stock | Tax liability | $20,311 | -1,228 | -0.22% | $16.54 | 567,331 | 03 Feb 2023 | Direct | F4 |
| transaction | CDNA | Common Stock | Tax liability | $20,311 | -1,228 | -0.22% | $16.54 | 566,103 | 03 Feb 2023 | Direct | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CDNA | Stock Option (right to buy) | Award | $0 | +156,000 | $0.000000 | 156,000 | 01 Feb 2023 | Common Stock | 156,000 | $15.66 | Direct | F8 |
| Id | Content |
|---|---|
| F1 | The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 1, 2024 and 1/4th of which shall vest on each anniversary thereafter. |
| F2 | Includes 177 shares acquired on January 2, 2023 pursuant to the Issuer's 2014 Employee Stock Purchase Plan. |
| F3 | The reported securities were subject to a performance restricted stock unit award that was initially granted on February 3, 2021 for a two-year performance period over calendar years 2021 and 2022, which performance was assessed and finalized effective February 1, 2023. 50.00% of the reported securities vested on February 1, 2023 and 50% of the reported securities will vest on December 31, 2023, subject to the Reporting Person's continued service with the Issuer. |
| F4 | These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. |
| F5 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.40 to $17.34, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.44 to $17.61, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| F8 | 1/4th of the shares subject to the option shall vest on February 2, 2024 and 1/48th of the shares subject to the option shall vest monthly thereafter. |
President and Chief Executive Officer